1 hr ago | P&T Community
FDA Approves Radium Drug Xofigo for Metastatic Prostate Cancer
The FDA has approved Xofigo for the treatment of men with symptomatic late-stage castration-resistant prostate cancer that has spread to bones but not to other organs.
On December 19th, 2012, Oncothyreon's shares fell roughly 50% as development partner Merck KGaA reported that L-BLP25 , a cancer immunotherapy that was being tested against non small-cell lung cancer , failed to meet its primary endpoint in a Phase III trial.
Advanced Prostate Cancer Drug Xofigo Approved By FDA
Xofigo has been approved by the US FDA for symptomatic late-stage castration-resistant prostate cancer that has reached bones but not other organs, i.e. with no known visceral metastatic disease.
Comorbidities Taken Into Account Before Prostate Biopsy
UC Irvine Health urologists and health policy experts report in a new study that two written assessments that identify existing comorbidities - the patient-reported Total Illness Burden Index for Prostate Cancer and the physician-reported Charlson Comorbidity Index - can successfully target prostate patients who would not benefit from biopsy to ... (more)
Carer payments boosted in record health budget
Family members will be paid to look after their disabled adult relatives after the Government set aside $23 million for carer payments in this year's Budget.
The Mountaineer Publishing Company
Early prostate cancer testing can be a lifesaver
During routine bloodwork, my PSA showed a slight movement upward. My family doctor wanted me to see a urologist for further tests.
Tommy Chong Is "Cancer Free;" Claims Marijuana Cures Cancer
Legendary comedian and noted pot enthusiast Tommy Chong has announced that he is cancer-free and claims he has his longtime friend Mary Jane to thank for his good health.
Androgen Deprivation Therapy For Prostate Cancer Can Cause Osteoporosis
Main Category: Prostate / Prostate Cancer Also Included In: Bones / Orthopedics ; Urology / Nephrology Article Date: 16 May 2013 - 1:00 PDT Androgen deprivation therapy is a common and effective treatment for advanced prostate cancer .
'Universal language of beer' helps nonprofit reach men about cancer awareness
That's the slogan of Pints for Prostate . As part of American Craft Beer Week, the Somerset Hills Hotel Tap Room will host a benefit Friday night for the organization, to help boost prostate cancer awareness through what the nonprofit calls the "universal language of beer." Pints for Prostates, a grassroots campaign started by cancer survivor Rick ... (more)
Fitness in middle age may help shield men from cancer later
Men who are physically fit in middle age have a lower risk of developing and dying from certain cancers, new research indicates.
Australian Broadcasting Corporation
Prostate cancer testing: who needs it? - iStockPhoto
New overseas guidelines on who should be tested for the second-most-common cause of cancer deaths in Australian men were released recently.
Volunteer photographers snapping free portraits of cancer patients
When you or your loved ones are in the middle of a cancer fight, the last thing on your mind is a portrait.
New TIME Cover: The Angelina Effect
Angelina Jolie has never lacked for influence. When she adopted a baby from Ethiopia, inquiries at U.S. adoption agencies about other Ethiopian orphans doubled.
Prostate Cancer and Prostatic Diseases
Hyperglycemia and prostate cancer recurrence in men treated for localized prostate cancer
Correspondence: Dr JL Wright, Department of Urology, University of Washington School of Medicine, 1959 NE Pacific, Box 356510, Seattle, WA 98195, USA.
Prostate Cancer and Prostatic Diseases
Assessing the order of critical alterations in prostate cancer...
ERG rearrangements and PTEN loss are two of the most common genetic alterations in prostate cancer.
Prostate Cancer and Prostatic Diseases
Distinct ERG rearrangement prevalence in prostate cancer: higher...
Correspondence: Dr F Demichelis, Centre for Integrative Biology, University of Trento, Via Sommarive, 14, Povo—Trento 38123, Italy E-mail: demichelis@science.unitn.it ; Dr H Klocker, Department of Urology, Innsbruck Medical University, Anichstr 35, Innsbruck 6020, Austria.
FDA Approves New Drug to Fight Advanced Prostate Cancer
The U.S. Food and Drug Administration announced Wednesday that it has approved a drug to help men with advanced prostate cancer whose disease has spread to the bones.
FDA approves radiation-based prostate cancer drug
The Food and Drug Administration has approved a new injectable drug that uses radiation to treat advanced prostate cancer that has spread to the bones.
Bayer, Algeta win FDA approval for prostate cancer drug
German drugmaker Bayer and its development partner Algeta won approval from U.S. regulators for a prostate cancer drug that could eventually generate more than 1 billion euros in annual sales.
Tokai Pharmaceuticals raises $35.5M to advance prostate cancer treatment
Cambridge biopharma Tokai Pharmaceuticals Inc. has raised a $35.5M Series E round of funding led by current investors and undisclosed angel investors.